ADENOSINE THERAPEUTICS, LLC

Organization

CHARLOTTESVILLE, VA, US

Business Address
300 PRESTON AVENUE 5TH FLOOR CHARLOTTESVILLE VA 22902 434-971-6800
State Location
VA
State of Incorporation

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Adenosine derivative formulations for medical imaging
- Patent number 9,555,129
- Issue date Jan 31, 2017
- Adenosine Therapeutics, LLC
- Ajit B. Thakur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonists of A2A adenosine receptors for treating recurrent tumor gr...
- Patent number 8,551,972
- Issue date Oct 8, 2013
- Adenosine Therapeutics, LLC
- Onno Kranenburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B ad...
- Patent number 7,470,697
- Issue date Dec 30, 2008
- Adenosine Therapeutics, LLC
- Guoquan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 8-heteroaryl xanthines
- Patent number 7,342,006
- Issue date Mar 11, 2008
- Adenosine Therapeutics, LLC
- Guoquan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective antagonists of A2A adenosine receptors
- Patent number 7,217,702
- Issue date May 15, 2007
- Adenosine Therapeutics, LLC
- Anthony Beauglehole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GR...
- Publication number 20140213541
- Publication date Jul 31, 2014
- Adenosine Therapeutics, LLC
- Onno Kranenburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 8-[6-AMINO-3PYRIDYL]XANTHINES
- Publication number 20090163491
- Publication date Jun 25, 2009
- Adenosine Therapeutics, Ltd.
- Robert D. Thompson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GR...
- Publication number 20080262001
- Publication date Oct 23, 2008
- Adenosine Therapeutics, LLC
- Onno Kranenburg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS
- Publication number 20080176858
- Publication date Jul 24, 2008
- Adenosine Therapeutics, LLC
- Anthony Beauglehole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
86571540 - STEDIVAZE
- Serial number 86571540
- Filing date Mar 20, 2015
- ADENOSINE THERAPEUTICS, LLC
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77521907 - STEDIVAZE
- Serial number 77521907
- Filing date Jul 14, 2008
- ADENOSINE THERAPEUTICS, LLC
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 30

Research Projects

Information Research Project
Antagonists of A2B Adenosine Receptors for Asthma
- Application id 7279868
- Award notice date Sep 7, 2007
Information Research Project
Safety of Adenosine A2a Agonist for Treatment of Sepsis
- Application id 7247106
- Award notice date Jul 12, 2007
Information Research Project
Adenosine A2A receptor antagonists for the treatment of cocaine add...
- Application id 7155456
- Award notice date May 24, 2007
Information Research Project
Antagonists of A2B Adenosine Receptors for Asthma
- Application id 7155367
- Award notice date Aug 24, 2006
Information Research Project
A2A AR Agonists as Adjunct Therapy Against S. aureus Sepsis
- Application id 7155473
- Award notice date Aug 22, 2006
Information Research Project
A2a AR Agonists for Rheumatoid Arthritis
- Application id 7108042
- Award notice date Aug 10, 2006
Information Research Project
Safety of A2A Adenosine Agonist for Treatment of Sepsis
- Application id 7108075
- Award notice date Jun 16, 2006
Information Research Project
A2A Adenosine Receptor Agonist for the Treatment of IBD
- Application id 6896593
- Award notice date Sep 26, 2005
Information Research Project
A2a Adenosine Agonists for Diabetic Nephropathy
- Application id 6994248
- Award notice date Sep 19, 2005
Information Research Project
Novel A2A Adenosine Agonists in Vascular Protection
- Application id 6950277
- Award notice date Aug 29, 2005
Information Research Project
A2a Adenosine Agonist Cardiac Reperfusion Injury
- Application id 6937332
- Award notice date Jun 20, 2005
Information Research Project
Antagonists of A2B Receptors Improve Insulin Sensitivity
- Application id 6883184
- Award notice date Mar 25, 2005
Information Research Project
A2a Adenosine Blockers for Parkinson's Disease
- Application id 6882125
- Award notice date Jan 26, 2005
Information Research Project
Novel A2A Adenosine Agonists in Vascular Protection
- Application id 6833020
- Award notice date Sep 17, 2004
Information Research Project
A2A Adenosine Receptor Agonist for the Treatment of IBD
- Application id 6741790
- Award notice date May 21, 2004
Information Research Project
Antagonists of A2B Receptors Improve Insulin Sensitivity
- Application id 6738727
- Award notice date Apr 9, 2004
Information Research Project
A2a Adenosine Agonists as Neuroprotectants
- Application id 6683294
- Award notice date Sep 12, 2003
Information Research Project
Novel Adenosine A2A Agonists in Renal Tissue Protection
- Application id 6603571
- Award notice date Aug 15, 2003
Information Research Project
A2a Adenosine Agonists Limit Damage from Infection
- Application id 6626001
- Award notice date May 19, 2003
Information Research Project
A2A Adenosine Agonist Adjunct for Systemic Anthrax
- Application id 6555424
- Award notice date Sep 20, 2002
Information Research Project
A2a Adenosine Agonists as Neuroprotectants
- Application id 6651489
- Award notice date Sep 15, 2002
Information Research Project
Novel Adenosine A2A Agonists in Renal Tissue Protection
- Application id 6483965
- Award notice date Jun 24, 2002
Information Research Project
A2a Adenosine Agonists Limit Damage from Infection
- Application id 6483754
- Award notice date May 6, 2002
Information Research Project
A2a Adenosine Agonists as Neuroprotectants
- Application id 6444325
- Award notice date Feb 7, 2002
Information Research Project
ANTAGONIST OF A2B ADENOSINE RECEPTORS FOR ASTHMA
- Application id 6293549
- Award notice date Sep 28, 2001
Information Research Project
Antagonists of A2B Receptors Improve Insulin Sensitivity
- Application id 6337815
- Award notice date Sep 13, 2001
Information Research Project
NOVEL ADENOSINE 2A AGONISTS IN RENAL TISSUE PROTECTION
- Application id 6204694
- Award notice date Sep 30, 2000
Information Research Project
A2A ADENOSINE AGONISTS LIMIT DAMAGE FROM INFECTION
- Application id 6072429
- Award notice date Jul 31, 2000
Information Research Project
NOVEL ADENOSINE A2A AGONISTS IN VASCULAR PROTECTION
- Application id 6206916
- Award notice date Jul 24, 2000
Information Research Project
IMPROVED VASODILATORS FOR PHARMACOLOGICAL STRESS IMAGING
- Application id 6074344
- Award notice date Jan 31, 2000

ADENOSINE THERAPEUTICS, LLC

Organization

Business Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Adenosine derivative formulations for medical imaging

Agonists of A2A adenosine receptors for treating recurrent tumor gr...

Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B ad...

Substituted 8-heteroaryl xanthines

Selective antagonists of A2A adenosine receptors

Patents Applicationslast 30 patents

AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GR...

SUBSTITUTED 8-[6-AMINO-3PYRIDYL]XANTHINES

AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GR...

SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS

Trademarklast 30 trademarks

86571540 - STEDIVAZE

77521907 - STEDIVAZE

NIH Research Projectlast 12 months

Research Projects

Antagonists of A2B Adenosine Receptors for Asthma

Safety of Adenosine A2a Agonist for Treatment of Sepsis

Adenosine A2A receptor antagonists for the treatment of cocaine add...

Antagonists of A2B Adenosine Receptors for Asthma

A2A AR Agonists as Adjunct Therapy Against S. aureus Sepsis

A2a AR Agonists for Rheumatoid Arthritis

Safety of A2A Adenosine Agonist for Treatment of Sepsis

A2A Adenosine Receptor Agonist for the Treatment of IBD

A2a Adenosine Agonists for Diabetic Nephropathy

Novel A2A Adenosine Agonists in Vascular Protection

A2a Adenosine Agonist Cardiac Reperfusion Injury

Antagonists of A2B Receptors Improve Insulin Sensitivity

A2a Adenosine Blockers for Parkinson's Disease

Novel A2A Adenosine Agonists in Vascular Protection

A2A Adenosine Receptor Agonist for the Treatment of IBD

Antagonists of A2B Receptors Improve Insulin Sensitivity

A2a Adenosine Agonists as Neuroprotectants

Novel Adenosine A2A Agonists in Renal Tissue Protection

A2a Adenosine Agonists Limit Damage from Infection

A2A Adenosine Agonist Adjunct for Systemic Anthrax

A2a Adenosine Agonists as Neuroprotectants

Novel Adenosine A2A Agonists in Renal Tissue Protection

A2a Adenosine Agonists Limit Damage from Infection

A2a Adenosine Agonists as Neuroprotectants

ANTAGONIST OF A2B ADENOSINE RECEPTORS FOR ASTHMA

Antagonists of A2B Receptors Improve Insulin Sensitivity

NOVEL ADENOSINE 2A AGONISTS IN RENAL TISSUE PROTECTION

A2A ADENOSINE AGONISTS LIMIT DAMAGE FROM INFECTION

NOVEL ADENOSINE A2A AGONISTS IN VASCULAR PROTECTION

IMPROVED VASODILATORS FOR PHARMACOLOGICAL STRESS IMAGING